Rockefeller Capital Management’s Mereo BioPharma MREO Stock Holding History

Rockefeller Capital Management’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$635	Hold	2,000	–	–	﹤0.01%	4573
2026 Q1	$660	Hold	2,000	–	–	﹤0.01%	4539
2025 Q4	$833	Hold	2,000	–	–	﹤0.01%	4475
2025 Q3	$4.12K	Buy	+2,000	New	+$3.69K	﹤0.01%	3930
2023 Q1	–	Sell	-358	Closed	–	–	3162
2022 Q4	$0	Hold	358	–	–	﹤0.01%	4079
2022 Q3	$0	Hold	358	–	–	﹤0.01%	4196
2022 Q2	$0	Hold	358	–	–	﹤0.01%	4288
2022 Q1	$0	Hold	358	–	–	﹤0.01%	3997
2021 Q4	$0	Hold	358	–	–	﹤0.01%	3909
2021 Q3	$0	Hold	358	–	–	﹤0.01%	3790
2021 Q2	$1K	Hold	358	–	–	﹤0.01%	3355
2021 Q1	$1K	Hold	358	–	–	﹤0.01%	3189
2020 Q4	$1K	Hold	358	–	–	﹤0.01%	2751
2020 Q3	$0	Hold	358	–	–	﹤0.01%	2705
2020 Q2	$1K	Hold	358	–	–	﹤0.01%	2467
2020 Q1	$0	Hold	358	–	–	﹤0.01%	2433
2019 Q4	$1K	Hold	358	–	–	﹤0.01%	1993
2019 Q3	$1K	Buy	+358	New	+$1.08K	﹤0.01%	1865

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Rockefeller Capital Management's MREO Position: Q2 2026 in Review

Rockefeller Capital Management held its Mereo BioPharma (MREO) position steady in Q2 2026 at 2,000 shares worth $635. The position accounts for ﹤0.01% of the portfolio, ranked #4573.

Rockefeller Capital Management first reported a position in MREO in Q3 2019 and has held it in 18 quarters since. The position peaked at $4.12K in Q3 2025. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Rockefeller Capital Management held 2,000 shares of Mereo BioPharma worth $635 as of Q2 2026.
Rockefeller Capital Management left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4573 holding.
Rockefeller Capital Management first reported a position in Mereo BioPharma in Q3 2019 and has held it in 18 quarters since.
Rockefeller Capital Management's Mereo BioPharma position peaked at $4.12K in Q3 2025.
61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.